Tag Archive for Revenue Growth

Zinzino Publishes Preliminary January 2026 Sales Report

Zinzino group revenue increased with a total of 20%, compared with the previous year.
Gothenburg, Sweden – Zinzino AB (publ) (ZZ-B.ST), a leading global direct selling company, reports that the revenue in January for Zinzino’s sales markets increased by 20% and amounted to SEK 274.1 (229.2) million.
Faun Pharma’s external sales increased and amounted to SEK 7.1 (4.7) million.
Overall, the Group increased revenues by 20% to SEK 281.2 (233.9) million compared with the previous year.
Revenues were distributed as follows:

Regions, mSEK
26-Jan
25-Jan
Change

The Nordics
27.3
25.9
5%

Central Europe
90.1
69.4
30%

East Europe
29.4
34.2
-14%

South & West Europe
46.6
44.1
6%

The Baltics
10.5
10.4
1%

North America
41.3
21.3
94%

South America
4.0
0.9
344%

Asia-Pacific
23.0
21.5
7%

Africa
1.9
1.5
27%

Zinzino
274.1
229.2
20%

Faun Pharma
7.1
4.7
51%

Zinzino Group
281.2
233.9
20%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
South America: Peru, Colombia
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
Africa: South Africa

About Zinzino
Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.
Zinzino’s scientifically proven nutritional supplements are available in more than

Read more...

Zinzino Preliminary Sales Report 2025

Zinzino group revenue increased 46% in Q4 and total revenue for the full year 2025 increased 51%, compared with the previous year.
The revenue in December for Zinzino‘s sales markets increased by 35% and amounted to SEK 334.4 (246.9) million. Faun Pharma’s external sales decreased and amounted to SEK 2.9 (5.8) million. Overall, the Group increased revenues by 33% to SEK 337.3 (252.7) million compared with the previous year.
Revenue in Zinzino’s sales markets increased by 50% in the fourth quarter of 2025 compared with the same period last year and amounted to SEK 1,032.3 (690.3) million. Total revenues in the Group increased by 46% in the fourth quarter and amounted to SEK 1,042.4 (713.5) million.
Accumulated revenue for January – December 2025 increased by 51% to SEK 3,344.5 (2,207.8) million.
Revenues were distributed as follows:

Regions, mSEK
25-Dec
24-Dec
Change
Q4 2025
Q4 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
31.4
29.6
6%
98.4
88.0
12%
332.5
302.0
10%

Central Europe
102.9
78.1
32%
337.9
202.3
67%
995.4
596.7
67%

East Europe
36.3
34.5
5%
122.0
120.6
1%
398.0
400.4
-1%

South & West Europe
53.7
49.7
8%
167.8
131.9
27%
565.8
396.4
43%

The Baltics
18.0
12.0
50%
48.3
38.2
26%
133.5
107.6
24%

North America
52.0
21.1
146%
163.8
66.3
147%
545.7
200.5
172%

Asia-Pacific
37.4
20.2
85%
86.2
37.1
132%
299.4
84.6
254%

Africa
2.7
1.7
59%
7.8
5.9
32%
23.8
16.8
42%

Zinzino
334.4
246.9
35%
1,032.3
690.3
50%
3,294.1
2,105.0
56%

Faun Pharma
2.9
5.8
-50%
10.1
23.2
-57%
50.4
102.8
-51%

Zinzino Group
337.3
252.7
33%
1,042.4
713.5
46%
3,344.5
2,207.8
51%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong

Read more...

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.
The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.
Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.
Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.
Revenues were distributed as follows:

Regions, mSEK
25-Sep
24-Sep
Change
Q3 2025
Q3 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
26.5
25.4
4%
79.6
72.5
10%
235.1
214.0
10%

Central Europe
93.8
48.7
93%
242.8
138.6
75%
657.9
394.4
67%

East Europe
29.4
28.3
4%
89.7
88.3
2%
276.2
279.9
-1%

South & West Europe
50.1
38.0
32%
137.2
104.2
32%
399.2
264.5
51%

The Baltics
8.9
7.2
24%
28.6
21.9
31%
85.3
69.4
23%

North America
41.3
20.3
103%
129.8
52.6
147%
382.1
134.0
185%

Asia-Pacific
21.6
9.6
125%
63.7
22.3
186%
212.7
47.5
348%

Africa
1.9
1.2
58%
5.8
4.0
46%
16.0
10.9
47%

Zinzino
273.5
178.7
53%
777.3
504.4
54%
2264.5
1414.6
60%

Faun Pharma
3.7
5.8
-36%
9.4
28.4
-67%
40.4
79.7
-49%

Zinzino Group
277.2
184.5
50%
786.7
532.8
48%
2304.9
1494.3
54%

Countries in regions:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
– Central Europe: Austria, Germany, Switzerland
– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
– The Baltics: Estonia, Latvia, Lithuania
– North America: Canada, USA, Mexico
– Asia-Pacific: Australia, New Zealand, Hong

Read more...

Zinzino Preliminary Sales Report, April 2025

Zinzino group revenue increased with a total of 54 %, compared with the previous year.
The revenue in April for Zinzino’s sales markets increased by 58 % and amounted to SEK 249.5 (158.0) million. Faun Pharma’s external sales decreased and amounted to SEK 6.2 (8.2) million.
Overall, the Group increased revenues by 54 % to SEK 255.7 (166.2) million compared with the previous year.
Accumulated revenue for January–April 2025 increased by 58 % to SEK 979.4 (620.7) million.
Revenues were distributed as follows:

Regions (MSEK)
Apr 2025 
Apr 2024 
Change 
YTD 2025 
YTD 2024 
Change 

The Nordics
23.5
25.0
-6%
100.7
93.0
8%

Central Europe
65.6
45.5
44%
262.0
165.0
59%

East Europe
27.2
31.1
-13%
124.4
124.9
0%

South & West Europe
45.0
26.4
70%
169.9
97.1
75%

The Baltics
8.7
8.2
6%
37.4
32.0
17%

North America
51.5
15.3
237%
164.0
50.7
223%

Asia-Pacific
26.3
5.4
387%
92.1
17.8
417%

Africa
1.7
1.1
55%
6.7
4.4
52%

Zinzino
249.5
158.0
58%
957.2
584.9
64%

Faun Pharma
6.2
8.2
-24%
22.2
35.8
-38%

Zinzino Group
255.7
166.2
54%
979.4
620.7
58%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

Central Europe: Austria, Germany, Switzerland

East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

The Baltics: Estonia, Latvia, Lithuania

North America: Canada, USA, Mexico

Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

Africa: South Africa

To view the full press release, please visit zinzino.com
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven

Read more...